106 related articles for article (PubMed ID: 4763037)
41. Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.
Murray JL; Ishmael DR; Bottomley RH; Grozea PN; Lee ET
Cancer Treat Rep; 1983 Feb; 67(2):191-2. PubMed ID: 6825130
[No Abstract] [Full Text] [Related]
42. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
[No Abstract] [Full Text] [Related]
43. [Clinical aspects and therapy of malignant melanoma].
Storck H
Hautarzt; 1970 Apr; 21(4):187-94. PubMed ID: 5524565
[No Abstract] [Full Text] [Related]
44. [On the treatment of skin melanoma].
Volodina GI; Abdullin AS
Vopr Onkol; 1966; 12(1):84-6. PubMed ID: 5973081
[No Abstract] [Full Text] [Related]
45. [Clinical trials of chemotherapy and chemoimmunotherapy of malignant melanoma with unfavorable prognosis after surgical treatment].
Dobrek Z
Wiad Lek; 1985 Feb; 38(4):265-70. PubMed ID: 3892918
[No Abstract] [Full Text] [Related]
46. Adjuvant therapy of malignant melanoma.
Vosika GJ
Minn Med; 1979 Jul; 62(7):515-7. PubMed ID: 386072
[No Abstract] [Full Text] [Related]
47. [Immunotherapy of malignant melanoma].
Adler A
Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
[No Abstract] [Full Text] [Related]
48. Five-year follow-up of 16 melanoma patients with a Starz I-involved sentinel node in whom completion lymph node dissection was omitted.
Veenstra HJ; Brouwer OR; van der Ploeg IM; Kroon BB; Nieweg OE
Melanoma Res; 2012 Dec; 22(6):436-9. PubMed ID: 22975764
[TBL] [Abstract][Full Text] [Related]
49. [Therapy of skin and venereal diseases. Literature review 1970-71].
Dtsch Med J; 1972 Jun; 23(6):XVI-XXIX contd. PubMed ID: 4263822
[No Abstract] [Full Text] [Related]
50. [Comparative characteristics of the results of treating melanomas of the skin surgically, radiologically or by combined methods].
Shanin AP
Vopr Onkol; 1967; 13(11):110-5. PubMed ID: 4876548
[No Abstract] [Full Text] [Related]
51. [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
Nepomniashchaia EM; Gusareva MA; Petrov SV
Vopr Onkol; 2008; 54(6):744-8. PubMed ID: 19241851
[TBL] [Abstract][Full Text] [Related]
52. [Radiotherapy with intra-arterial chemotherapy. Treatment with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide. Effect in malignant melanoma of the extremities].
Gundersen S; Hager B; Tausjø J
Tidsskr Nor Laegeforen; 1985 Aug; 105(24):1617-9. PubMed ID: 4060116
[No Abstract] [Full Text] [Related]
53. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
54. [Treatment of experimental tumors with laser beams in combination with fast electrons].
Kozlov AL; Akimov AA; Moskalik KG
Vopr Onkol; 1973; 19(6):93-7. PubMed ID: 4205007
[No Abstract] [Full Text] [Related]
55. Surgical treatment of malignant melanoma.
Rosenberg SA
Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
[TBL] [Abstract][Full Text] [Related]
56. [Pattern of recurrence of surgically treated primary malignant melanomas of the skin. Therapeutic consequences (author's transl)].
Lukacs S; Braun-Falco O; Troot KR; Hug O
MMW Munch Med Wochenschr; 1977 Mar; 119(9):279-82. PubMed ID: 403460
[TBL] [Abstract][Full Text] [Related]
57. The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.
Danish HH; Patel KR; Switchenko JM; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
Melanoma Res; 2016 Dec; 26(6):595-603. PubMed ID: 27575390
[TBL] [Abstract][Full Text] [Related]
58. [On pigment tumors of the skin in children].
Hoppe-Wolfram E; Roth A
Radiobiol Radiother (Berl); 1968; 9(4):407-16. PubMed ID: 5699599
[No Abstract] [Full Text] [Related]
59. A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.
Kaufman HL; DeRaffele G; Divito J; Hörig H; Lee D; Panicali D; Voulo M
Hum Gene Ther; 2001 Jul; 12(11):1459-80. PubMed ID: 11485637
[No Abstract] [Full Text] [Related]
60. [Indications for and results of percutaneous radiotherapy of malignant melanoma].
Hellriegel W
Strahlentherapie; 1975 Jan; 149(1):1-20. PubMed ID: 1124549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
